🇮🇳IN
Sign In
SH

SHUKRAPHAR

NSE

Shukra Medtech Ltd

₹82.22

+0.02(+0.02%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

SHUKRAPHAR financial summary

For Mar 2026, Shukra Medtech Ltd reported revenue of ₹57 crore, which grew 72.7% from the previous year. Net profit was ₹22 crore, which grew 120.0% year on year, on an operating margin of 51%. Earnings per share came in at ₹0.5. Over the 5 years from Mar 2021 to Mar 2026, revenue changed at a compound annual rate of 39.0%. The highest operating margin in that period was 51% in Mar 2026. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹57 crore
Net profit₹22 crore
Operating margin51%
EPS₹0.5

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer